Jan 15, 2021 Sci Immunol
PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques
Kauffman, K.D., Sakai, S., Lora, N.E., Namasivayam, S., Baker, P.J., Kamenyeva, O., Foreman, T.W., Nelson, C.E., Oliveira-de-Souza, D., Vinhaes, C.L., Yaniv, Z., Lindestam Arleham, C.S., Sette, A., Freeman, G.J., Moore, T; NIAID/DIR Tuberculosis Imaging Program, Sher, A., Mayer-Barber, K.D., Andrade, B.B., Kabat, J., Via, L.E., and Barber, D.L.
Dec 8, 2020 Lancet Respir Med
Safety and immunogenicity of the adjunct therapeutic vaccine ID93+ GLA-SE in adult who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial
Day, T.A., Penn-Nicholson, A., Luabeya, A.K.K., Fiore-Gartland, A., Du Plessis, N., Loxton, A.G., Vergara, J., Rolf, T.A., Reid, T.D., Toefy, A., Shenje, J., Geldenhuys, H., Tameris, M., Mabew, S., Bilek, N., Bekker, L.G., Diacon, A., Walzl, G., Ashman, J., Frevol, A., Sagawa, Z.K., Lindestam Arlehamn, C., Sette, A., Reed, S.G., Coler, R.N., Scriba, T.J., Hatherill, M.; TBVPX-203 study team